Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ramazan Idilman & Mutlu Arat. (2011) Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation. Expert Review of Anti-infective Therapy 9:8, pages 641-652.
Read now
Read now
Münci Yađcý, Kadýr Acar, Gülsan Türköz Sucak, Zeynep Aki, Gülendam Bozdayi & Rauf Haznedar. (2006) A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. Leukemia & Lymphoma 47:8, pages 1608-1612.
Read now
Read now
Articles from other publishers (33)
Xiaoguang Wang, Xiaodan Yang, Fei Chen, Shaohan Wu, Zhengwei Song & Jianguo Fei. (2021) Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-6.
Crossref
Crossref
Loris Lopetuso, Giammarco Mocci, Manuela Marzo, Francesca D’Aversa, Gian Rapaccini, Luisa Guidi, Alessandro Armuzzi, Antonio Gasbarrini & Alfredo Papa. (2018) Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the Liver. International Journal of Molecular Sciences 19:8, pages 2199.
Crossref
Crossref
Shujun Ma. (2015) Research advances in reactivation of hepatitis virus after chemotherapy for non-Hodgkin’s lymphoma-combined hepatitis B virus infection. Infection International 4:3, pages 75-80.
Crossref
Crossref
Shingo Nakamoto, Tatsuo Kanda, Chiaki Nakaseko, Emiko Sakaida, Chikako Ohwada, Masahiro Takeuchi, Yusuke Takeda, Naoya Mimura, Tohru Iseki, Shuang Wu, Makoto Arai, Fumio Imazeki, Kengo Saito, Hiroshi Shirasawa & Osamu Yokosuka. (2014) Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment. International Journal of Molecular Sciences 15:11, pages 21455-21467.
Crossref
Crossref
Fan Yang, Huan-Ling Zhu, Chuan He, Jian-Jun Li, Bing Xiang, Xu Cui, Jie Huang, Jie Ji, Hong-Bing Ma & Ting Liu. (2012) Effect of Antiviral Prophylaxis Strategy for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin’s Lymphoma Patients with Hepatitis B Virus Infection: A Retrospective Cohort Study. Indian Journal of Hematology and Blood Transfusion 30:2, pages 97-104.
Crossref
Crossref
Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong & Qiyu Zhang. (2013) Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis. Hepatitis Monthly 13:4.
Crossref
Crossref
M. Mouler Rechtman, E. O. Burdelova, I. Bar‐Yishay, M. Ben‐Yehoyada, S. Fishman, Z. Halpern & A. Shlomai. (2012) The metabolic regulator PGC‐1α links anti‐cancer cytotoxic chemotherapy to reactivation of hepatitis B virus. Journal of Viral Hepatitis 20:1, pages 34-41.
Crossref
Crossref
Jeong Won Jang. (2012) Management of Patients with Hepatitis B Virus Infection Who Receive Immunosuppressive Treatment or Chemotherapy. Korean Journal of Medicine 82:2, pages 149.
Crossref
Crossref
Joong Ho BaeJoo Hyun SohnHye Soon LeeHye Sun ParkYil Sik HyunTae Yeob KimChang Soo EunYong Cheol JeonDong Soo Han. (2012) A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier. Clinical and Molecular Hepatology 18:2, pages 225.
Crossref
Crossref
Jeryl Villadolid, Kourtney D. LaPlant, Merry Jennifer Markham, David R. Nelson & Thomas J. GeorgeJr.Jr.. (2010) Hepatitis B Reactivation and Rituximab in the Oncology Practice. The Oncologist 15:10, pages 1113-1121.
Crossref
Crossref
RA Herbertson & A Webb. (2010) High grade lymphoma: acute presentation and management. British Journal of Hospital Medicine 71:5, pages 252-257.
Crossref
Crossref
. (2010) Anforderungen an die Hygiene bei der medizinischen Versorgung von immunsupprimierten PatientenRequirements for hygiene in the medical care of immunocompromised patients. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 53:4, pages 357-388.
Crossref
Crossref
Tara N. Palmore, Neeral L. Shah, Rohit Loomba, Brian B. Borg, Uri Lopatin, Jordan J. Feld, Farooq Khokhar, Glen Lutchman, David E. Kleiner, Neal S. Young, Richard Childs, A. John Barrett, T. Jake Liang, Jay H. Hoofnagle & Theo Heller. (2009) Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression. Clinical Gastroenterology and Hepatology 7:10, pages 1130-1137.
Crossref
Crossref
Toru Takahashi, Tadashi Koike, Shigeo Hashimoto, Tomofumi Miura, Junichiro Nakamura, Satoshi Yamada, Tsutomu Miura, Masahiko Yanagi, Kazuhide Yamazaki, Shogo Okoshi & Yutaka Aoyagi. (2008) A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma. Hepatology International 3:1, pages 316-322.
Crossref
Crossref
Halim Charbel & James H. Lewis. 2010. Chronic Viral Hepatitis. Chronic Viral Hepatitis
307
336
.
Feng Wang, Rui-hua Xu, Hui-yan Luo, Dong-shen Zhang, Wen-qi Jiang, Hui-qiang Huang, Xiao-fei Sun, Zhong-jun Xia & Zhong-zhen Guan. (2008) Clinical and prognostic analysis of hepatitis B virus infection in diffuse large B-cell lymphoma. BMC Cancer 8:1.
Crossref
Crossref
S. Domm, J. Cinatl & U. Mrowietz. (2008) The impact of treatment with tumour necrosis factor-α antagonists on the course of chronic viral infections: a review of the literature. British Journal of Dermatology 159:6, pages 1217-1228.
Crossref
Crossref
Jesús Sanz Sanz, Lucía Silva Fernández, José Luis Calleja Panero, Mónica Fernández-Castro & José Luis Andreu Sánchez. (2008) Infliximab en la espondilitis anquilosante asociada a infección crónica por el virus de la hepatitis B. Papel del tratamiento con lamivudina. Reumatología Clínica 4:4, pages 159-161.
Crossref
Crossref
Jesús Sanz Sanz, Lucía Silva Fernández, José Luis Calleja Panero, Mónica Fernández-Castro & José Luis Andreu Sánchez. (2008) Infliximab in Ankylosing Spondylitis Associated With Chronic Hepatitis B Infection. Role of Lamivudine Therapy. Reumatología Clínica (English Edition) 4:4, pages 159-161.
Crossref
Crossref
Holbrook E. Kohrt, Daniel L. Ouyang & Emmet B. Keeffe. (2007) Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection. Clinics in Liver Disease 11:4, pages 965-991.
Crossref
Crossref
Anne Thirot-Bidault, Jaata Ben Mansour, Olivier Lambotte, Caroline Besson, Rita Bou-Farah, Coralie Pallier & Catherine Buffet. (2007) Évolution fatale après réactivation d’une hépatite chronique virale B occulte dans les suites d’une chimiothérapie pour lymphome chez un malade porteur de l’anticorps anti-HBc isolé. Gastroentérologie Clinique et Biologique 31:11, pages 1028-1031.
Crossref
Crossref
Münci Yağcı, Kadir Acar, Gülsan Türköz Sucak, Kadri Yamaç & Rauf Haznedar. (2007) Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant. European Journal of Haematology 79:4, pages 292-296.
Crossref
Crossref
Chia Hung Chou, Pei-Jer Chen, Po-Huang Lee, Ann-Lii Cheng, Hui-Chen Hsu & Jason Chia-Hsien Cheng. (2007) Radiation-Induced Hepatitis B Virus Reactivation in Liver Mediated by the Bystander Effect from Irradiated Endothelial Cells. Clinical Cancer Research 13:3, pages 851-857.
Crossref
Crossref
H. E. KOHRT, D. L. OUYANG & E. B. KEEFFE. (2006) Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Alimentary Pharmacology and Therapeutics 24:7, pages 1003-1016.
Crossref
Crossref
A. Alexopoulou, M. Theodorou, S. P. Dourakis, P. Karayiannis, E. Sagkana, K. Papanikolopoulos & A. J. Archimandritis. (2006) Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutations. Journal of Viral Hepatitis 13:9, pages 591-596.
Crossref
Crossref
Sonia Maciá Escalante, Álvaro Rodríguez Lescure, Mariana Fe García Sepulcre, Carmen Guillén Ponce & Alfredo Carrato Mena. (2006) Paciente con reactivación de hepatitis b tras quimioterapia. Papel del tratamiento con lamivudina. Gastroenterología y Hepatología 29:7, pages 433.
Crossref
Crossref
Alexandra Alexopoulou, Spyros P. Dourakis, Helen Pandelidaki, Athanasios J. Archimandritis & Peter Karayiannis. (2006) Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine. Journal of Medical Virology 78:8, pages 1043-1046.
Crossref
Crossref
M. Sandherr, H. Einsele, H. Hebart, C. Kahl, W. Kern, M. Kiehl, G. Massenkeil, O. Penack, X. Schiel, S. Schuettrumpf, A.J. Ullmann & O.A. Cornely. (2006) Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of Oncology 17:7, pages 1051-1059.
Crossref
Crossref
L Fouillard, L Serfaty & J Gozlan. (2006) Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation. Bone Marrow Transplantation 37:6, pages 625-626.
Crossref
Crossref
Annarosa Floreani, Sara Boninsegna, Salvatore Lobello, Diego Caroli & Stefano Fagiuoli. (2006) Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. Gastroentérologie Clinique et Biologique 30:2, pages 307-309.
Crossref
Crossref
Ramazan Idilman. (2005) Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy. Journal of Antimicrobial Chemotherapy 55:6, pages 828-831.
Crossref
Crossref
Emilio Iannitto, Viviana Minardi, Giuseppina Calvaruso, Antonino Mule, Emanuele Ammatuna, Rosa D. Trapani, Donatella Ferraro, Vincenzo Abbadessa, Antonio Craxi & Rosa D. Stefano. (2005) Hepatitis B virus reactivation and alemtuzumab therapy. European Journal of Haematology 74:3, pages 254-258.
Crossref
Crossref
Cesare Sarrecchia, Alessandra Cappelli, Pasquale Aiello & Cesare Sarrecchia. (2005) HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. Journal of Infection and Chemotherapy 11:4, pages 189-191.
Crossref
Crossref